Resistance to pyrazinamide among Mycobacterium tuberculosis strains isolated from patients from the Mazovian Voivodeship in 2008-2010 years

Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 10

Abstract

Introduction. The anti-tuberculous properties of pyrazinamide (PZA) were identified over 50 years ago, and since that time it has been one of the most important drugs used for the treatment of tuberculosis, in addition RMP, INH, EMB i SM. Although PZA plays such an important role in the treatment of tuberculosis, the World Health Organisation (WHO) has not issued a recommendation to collect data on the prevalence of PZA resistance among Mycobacterium tuberculosis strains or to perform susceptibility testing for this drug. This mainly results from the difficulty of the PZA susceptibility test. It is therefore unknown how prevalent PZA resistance is worldwide.The aim of study. The aim of our study was to estimate the resistibility for PZA among M. tuberculosis isolates from patients from the Mazovian Voivodeship in 2008-2010 years.Material and methods. We analysed M. tuberculosis strains with different resistibility to first-line antituberculous drugs. The strains were isolated from 462 patients with tuberculosis. The strains were examined for PZA resistibility by the radiometric Bactec 460-TB method. The PZA-resistant strains were examined for the following MIC PZA for drug concentration: 100, 300, 600, 900 µg/ml.Results. PZA resistance among M. tuberculosis strains was found in 5,9% untreated patients and in 14% previously treated patients. In both groups resistance to PZA was correlated with drug resistance for INH+RMP+SM+EMB in 14% untreated patients and in 25% previously treated ones. The PZA-monoresistant strains were observed in 50% untreated patients groups.Among resistant strains for 23,5% strains MIC for PZA was > 100 μg/ml, for 17,6% MIC for PZA ≥ 300 μg/ml 14,7% ≥ 600 μg/ml and 44,1% ≥ 900 μg /ml.Conclusisons. Among M. tuberculosis strains PZA resistance was found in 5,9% untreated patients and in 14% previously treated patients.Among the PZA-resistant strains very high MIC value for PZA (≥ 900 µg/ml) was revealed for 44% M. tuberculosis strains.

Authors and Affiliations

Agnieszka Napiórkowska, Zofia Zwolska, Ewa Augustynowicz-Kopeć

Keywords

Related Articles

Hodgkin’s lymphoma

Hodgkin’s lymphoma (HL) is a chemosensitive B-cell malignant proliferation, with durable remission rates 80-90% among all treated patients. Approximately 95% of cases represent so called classical HL (cHL),...

Wewnątrznaczyniowe leczenie przetok szyjno-jamistych

Przetoki szyjno-jamiste są nieprawidłowymi połączeniami pomiędzy tętnicami szyjnymi i zatoką jamistą. Obecność tych połączeń skutkuje nadciśnieniem w obrębie żylnych naczyń drenujących.Rozwój technik wewnątrznaczyniowych...

Study on intra and intreobserver variability of prostate cancer grading

<b>Introduction.</b> Adenocarcinoma of the prostate is one of the most frequent cancer in man. Clinical stage and grade based on Gleason score scale are main circumstances according to which a...

Preoperative embolisation in spine/vertebrae tumors

Introduction. Neoplasmatic tumors within vertebrae column can be a cause of mielopathic changes. They also lead to increased risk of pathological fractions of influenced vertebrae. Both those reasons may proceed to serio...

Dziedziczny rak prostaty

Badania epidemiologiczne ostatniego dwudziestolecia dowodzą, że czynniki genetyczne mają ogromne znaczenie w etiologii raka gruczołu krokowego, jednakże geny związane z dziedziczną predyspozycją do tego nowotworu pozosta...

Download PDF file
  • EP ID EP54042
  • DOI -
  • Views 134
  • Downloads 0

How To Cite

Agnieszka Napiórkowska, Zofia Zwolska, Ewa Augustynowicz-Kopeć (2011). Resistance to pyrazinamide among Mycobacterium tuberculosis strains isolated from patients from the Mazovian Voivodeship in 2008-2010 years. Postępy Nauk Medycznych, 24(10), -. https://europub.co.uk./articles/-A-54042